Sunday, August 1, 2021

Researchers identify molecular ‘cookie cutter’ technique for COVID-19 drug discovery

Researchers from the University of Birmingham are aiming to isolate and extract the COVID-19 encounter complex for the identification of drug target sites for the disease.

The encounter complex is formed when the COVID-19 spike attaches onto a binding site on an ACE-2 receptor.

This is a complex protein embedded in cell membranes in the lungs and cells that line the nose and airways.

The encounter complex was first isolated last year, but these methods involved full extraction of ACE-2 receptors from cell membranes.

By removing the membrane’s supportive structure, the stability of the receptor is in turn affected. This makes it difficult to study its structure and function, said the University of Birmingham researchers.

The researchers are aiming to use polymer-based molecular ‘cookie cutters’ to isolate the encounter complex and ensure it remains embedded in the cell membrane.

The aim is to preserve the full structure of the molecule in its original form and keep it stable.

The researchers will use polymers known as Styrene Maleic Anhydrides, or SMAs, with the resulting structure known as an SMA lipid particle (SMALP).

The technique was invented by Professor Tim Dafforn from the University of Birmingham’s School of Biosciences.

The SMAs used in the study were provided by Orbiscope, a large-scale producer of SMAs for high-end applications.

Source link

Stay Connected


Latest Articles

Need to create vigilance and awareness on zoonotic diseases: India’s Health Minister

The COVID-19 pandemic has highlighted the need of creating vigilance and awareness on zoonotic diseases, informed Union Health Minister Mansukh Mandaviya while virtually inaugurating...

Covid’s second wave proves lethal for pregnant women

At SVP Hospital in Ahmedabad – one of the major Covid-19 hospitals of the city – 148 pregnant women with Covid-19 infection were admitted...

7 Tips to Keep Your Gut Healthy

This is common to say health (and illness) starts in your gut. If you have poor gut health, you’ll experience anything from wrinkled skin, to...

SII making first batch of Covovax: Poonawalla

The first batch of Covovax, a Covid-19 vaccine developed by Novavax Inc, is being manufactured at the Serum Institute of India's Pune facility, SII...

Sputnik V is safest among all Covid-19 vaccines, no deaths recorded: Buenos Aires study

A study by the Buenos Aires Ministry of Health to monitor the safety of the Sputnik V vaccine against Covid-19 confirmed on Thursday that...